Ashwini Madhukar Patil, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Viral Vaccines | 2 | 2020 | 596 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
| Coronaviridae | 1 | 2020 | 13 | 0.180 |
Why?
|
| Coronaviridae Infections | 1 | 2020 | 10 | 0.180 |
Why?
|
| Immunity, Herd | 1 | 2020 | 48 | 0.170 |
Why?
|
| Pandemics | 1 | 2020 | 8748 | 0.170 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2022 | 256 | 0.170 |
Why?
|
| Zoonoses | 1 | 2020 | 180 | 0.160 |
Why?
|
| Immunization, Passive | 1 | 2020 | 619 | 0.150 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2018 | 140 | 0.150 |
Why?
|
| Peptide Hydrolases | 1 | 2020 | 610 | 0.140 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2018 | 176 | 0.140 |
Why?
|
| Vaccinia | 1 | 2017 | 71 | 0.140 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2018 | 338 | 0.140 |
Why?
|
| Receptors, Virus | 1 | 2020 | 652 | 0.140 |
Why?
|
| Virus Internalization | 1 | 2020 | 504 | 0.130 |
Why?
|
| Genome, Viral | 1 | 2020 | 674 | 0.130 |
Why?
|
| Endocytosis | 1 | 2020 | 956 | 0.130 |
Why?
|
| Vaccinia virus | 1 | 2017 | 328 | 0.130 |
Why?
|
| Interferon Type I | 1 | 2017 | 569 | 0.110 |
Why?
|
| Virus Replication | 1 | 2020 | 2458 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 1613 | 0.100 |
Why?
|
| RNA, Viral | 1 | 2020 | 2872 | 0.100 |
Why?
|
| Forecasting | 1 | 2020 | 2945 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2017 | 1377 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2232 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3073 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2018 | 4035 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 3250 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7453 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4648 | 0.060 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2018 | 93 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2017 | 220 | 0.040 |
Why?
|
| Chimera | 1 | 2018 | 454 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 825 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 716 | 0.030 |
Why?
|
| Animals | 3 | 2020 | 169246 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 1968 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 2709 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 22379 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9561 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2018 | 9384 | 0.010 |
Why?
|
| Prognosis | 1 | 2022 | 30010 | 0.010 |
Why?
|
| Humans | 3 | 2022 | 768166 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9538 | 0.010 |
Why?
|
| Mice | 2 | 2018 | 82029 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10266 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 54926 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81762 | 0.010 |
Why?
|
| Female | 2 | 2018 | 397192 | 0.000 |
Why?
|
| Male | 1 | 2018 | 364719 | 0.000 |
Why?
|